Pre-pectoral Breast Reconstruction With or Without Mesh
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-65
SponsorTianjin Medical University Cancer Institute and Hospital
About this trial
To explore the efficacy and safety that occur after immediate prepectoral breast reconstruction when TiLOOP Mesh is used compared to that when TiLOOP Mesh is not used.
Eligibility criteria
Qualifiers
Adult women aged 18-65 years who plan to undergo unilateral or bilateral immediate prepectoral prothesis breast reconstruction;
SSM or NSM or Skin-Reducing Mastectomy for breast cancer patients or prophylactic mastectomy;
Tissue expander size =<800cc, implant size =<600cc;
The blood perfusion of breast skin flap was well;
Disqualifiers
Poor perfusion of breast mastectomy flap;
II stage breast reconstruction patients;
History of chest radiotherapy;
BMI greater than 35;
Trial design
Treatments tested in this trial
- prepectoral breast reconstruction
- Tiloop Mesh implantation
Treatment groups
164 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov